|
|
Volumn 30, Issue 1, 1996, Pages 29-34
|
|
Orphan drug development update
|
|
Author keywords
Marketing approval; Orphan Drug Act; Orphan product; Rare diseases and disorders
|
|
Indexed keywords
BACLOFEN;
BOTULINUM ANTISERUM;
CARNITINE;
CLADRIBINE;
HISTRELIN;
LORENZO OIL;
MERCAPTAMINE;
NAFARELIN ACETATE;
ORPHAN DRUG;
PEGADEMASE;
RETINOIC ACID;
SUCCIMER;
ACUTE MYELOBLASTIC LEUKEMIA;
ADRENOLEUKODYSTROPHY;
BOTULISM;
CARNITINE DEFICIENCY;
COMBINED IMMUNODEFICIENCY;
CYSTINOSIS;
DRUG APPROVAL;
DRUG LEGISLATION;
DRUG MARKETING;
FINANCE;
FOOD AND DRUG ADMINISTRATION;
HAIRY CELL LEUKEMIA;
LEAD POISONING;
LUNG EMBOLISM;
PRECOCIOUS PUBERTY;
PRIORITY JOURNAL;
REVIEW;
SPASTICITY;
|
|
EID: 0030022631
PISSN: 00928615
EISSN: None
Source Type: Journal
DOI: 10.1177/009286159603000104 Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
